Interesting tidbits on the Musk margin loan... The terms of the margin loan are 20% initial LTV with a 35% margin call level. This means that for a $12.5B loan, Musk must pledge $62.5B worth of $TSLA based on share price at closing, and gets called if TSLA drops ~43%.
BUT - Tesla's own rules on director/officer share pledges is actually stricter and imposes its own max level at 25% LTV. (Below is from the 2021 proxy statement).
Under this requirement only a 20% decrease in $TSLA price would trigger a call. Much smaller cushion
Finally, if you think he can satisfy his equity check ($21B ECL) by borrowing rather than selling... are... you sure? It took half of Wall Street to come up with $12.5bn... with 5x collateral cushion. $21bn more means $105B of collateral (and of course finding a lender)
The whole saga is undoubtedly entertaining and bizarre but there are still so many questions that really can't be answered until we see the actual merger agreement - conditionality, drop dead dates, break fees etc.
Personally, I find the dynamics fascinating. Like it seems like one of the largest and most complex buyouts in history was cobbled together in two weeks including a HUGE term loan, enormous margin loan on the most volatile and high performing stock, etc...
I like to imagine the calls to the lesser banks in the club like:
MS: hey are you in?
Mizuho: on what?
MS: Biggest deal of the decade
Mizuho: umm yea could you provide some more details?
MS: Biggest deal of the decade. Elon Musk. we are lead
Mizuho: Say no more fam
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1. No, it wasn't a joke. I think Blade $BLDE is one of the most underappreciated and undervalued stock in the market.
Revenue: 54%
Seats Flown: 45%
Largest organ transplant aviator in the country
👇👇
2. In just two years since entering the organ-transplant space, it has grown organically to be the largest player in the country. Its scale and platform has allowed it to outcompete and consolidate a fragmented regional industry. There is >70% of this market left to capture.
3. Despite the success in medical, investors are concerned about the impact of Transmedics' (TMDX) vertical integration and declining BLDE revenue over the past two quarters. Understandable... but they have it wrong.
1. I've looked through hundreds of discarded deSPACs and think Blade Air Mobility $BLDE is one of the most unappreciated and undervalued stocks in the market.
2. The company trades at a basic market cap of $209 million at $2.78/share, compared to $166 million of cash on the balance sheet at year end. The market says this business is worth almost nothing... which is odd...
3. Because the company has grown revenue ~3x in two years from $67m in 2021 to $225m 2023. Some of this growth has come via acquisition, but the biggest driver is its medical segment, where the company is the largest air transport provider for organ transplants in the country
Blackstone Mortgage Trust $BXMT reported 4Q23 results this morning.
Here are the implications for Arbor Realty Trust $ABR, before they report this Friday the 16th...
Bears should take note...🧵
$BXMT and $ABR have similarities - floating rate mREITs, both under scrutiny and the subject of short reports by @muddywatersre and @viceroyresearch, respectively. Some overlap in assets. Both reports make similar arguments around overstated collateral and future credit losses.
This morning $BXMT reported a significant build in credit provisions for the second quarter in a row.
The provision eliminated all GAAP profits for the quarter, resulting in a net loss of ($0.01)/sh